PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
D'Incecco, A, Andreozzi, M, Ludovini, V, Rossi, E, Capodanno, A, Landi, L, Tibaldi, C, Minuti, G, Salvini, J, Coppi, E, Chella, A, Fontanini, G, Filice, M E, Tornillo, L, Incensati, R M, Sani, S, Crinò, L, Terracciano, L, Cappuzzo, F
Published in British journal of cancer (06.01.2015)
Published in British journal of cancer (06.01.2015)
Get full text
Journal Article
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancer
Minuti, G, Cappuzzo, F, Duchnowska, R, Jassem, J, Fabi, A, O’Brien, T, Mendoza, A D, Landi, L, Biernat, W, Czartoryska-Arłukowicz, B, Jankowski, T, Zuziak, D, Zok, J, Szostakiewicz, B, Foszczyńska-Kłoda, M, Tempińska-Szałach, A, Rossi, E, Varella-Garcia, M
Published in British journal of cancer (21.08.2012)
Published in British journal of cancer (21.08.2012)
Get full text
Journal Article
The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer
Banna, G.L., Cortellini, A., Cortinovis, D.L., Tiseo, M., Aerts, J.G.J.V., Barbieri, F., Giusti, R., Bria, E., Grossi, F., Pizzutilo, P., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., Macerelli, M., Rastelli, F., Chiari, R., Rocco, D., Gori, S., De Tursi, M., Di Marino, P., Mansueto, G., Zoratto, F., Filetti, M., Montrone, M., Citarella, F., Marco, R., Cantini, L., Nigro, O., D'Argento, E., Buti, S., Minuti, G., Landi, L., Guaitoli, G., Lo Russo, G., De Toma, A., Donisi, C., Friedlaender, A., De Giglio, A., Metro, G., Porzio, G., Ficorella, C., Addeo, A.
Published in ESMO open (01.04.2021)
Published in ESMO open (01.04.2021)
Get full text
Journal Article
Integrating programmed cell death ligand 1 (PD-L1) and neutrophil to lymphocyte ratio (NLR) as predictive panel of response to nivolumab in non-small cell lung cancer (NSCLC)
Bennati, C., Mazza, V., D'Arcangelo, M., Minuti, G., Vecchiarelli, S., Attilia, L., Gili, A., Montanari, M., Landi, L., Cappuzzo, F.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
Role of TP53 mutations in relation to response to anti-ALK agents in EML4-ALK-translocated NSCLC patients
Canale, M., Delmonte, A., Dazzi, C., Gamboni, A., Casanova, C., Papi, M., Mariotti, M., De Luigi, N., Burgio, M.A., Minuti, G., Calistri, D., Bonafè, M., Crinò, L., Ulivi, P.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Circulating programmed death ligand-1 (PD-L1) in non-small cell lung cancer (NSCLC)
Vecchiarelli, S., D'Incecco, A., Gallo, M., De Luca, A., Minuti, G., Landi, L., Bennati, C., Spreafico, M., D'Arcangelo, M., Attilia, L., Mazza, V., Normanno, N., Cappuzzo, F.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
Programmed death ligand 1 (PD-L1) expression status as prognostic factor in early stage non-small cell lung cancer (NSCLC)
D'Arcangelo, M., Puccetti, M., Bravaccini, S., D'Incecco, A., Ligorio, C., Terracciano, L., Damiani, S., Bennati, C., Minuti, G., Vecchiarelli, S., Landi, L., Incarbone, M., Milesi, M., Ravaioli, S., Tumedei, M.M., Rossi, E., Cappuzzo, F.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database
Reale, M.L., Passiglia, F., Cappuzzo, F., Minuti, G., Occhipinti, M., Bulotta, A., Delmonte, A., Sini, C., Galetta, D., Roca, E., Pelizzari, G., Cortinovis, D., Gariazzo, E., Pilotto, S., Citarella, F., Bria, E., Muscolino, P., Pozzessere, D., Carta, A., Pignataro, D., Calvetti, L., Leone, F., Banini, M., Di Micco, C., Baldini, E., Favaretto, A., Malapelle, U., Novello, S., Pasello, G., Tiseo, M.
Published in ESMO open (01.09.2024)
Published in ESMO open (01.09.2024)
Get full text
Journal Article
Crizotinib in ROS1 rearranged or MET deregulated non-small-cell lung cancer (NSCLC): final results of the METROS trial
Landi, L., Chiari, R., Dazzi, C., Tiseo, M., Chella, A., Delmonte, A., Bonanno, L., Cortinovis, D., de Marinis, F., Minuti, G., Buosi, R., Morabito, A., Maione, P., Galetta, D., Barbieri, F., Grossi, F., Novello, S., Bruno, R., Fontanini, G., Crinò, L., Cappuzzo, F.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
1861 Body mass index and prognosis in HER2-positive metastatic breast cancer patients
Poletto, E, Minisini, A.M, Ferreira, A, Matteo, L, Poggio, F, Sottotetti, F, Montemurro, F, Pozzi, E, Rossi, V, Risi, E, Dellepiane, C, Sini, V, Ziliani, S, Minuti, G, Mura, S, Grasso, D, Bertolini, I, Del Mastro, L, Puglisi, F
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab
Vaglica, M, Lambertini, M, Ferreira, A, Poggio, F, Puglisi, F, Sottotetti, F, Montemurro, F, Poletto, E, Pozzi, E, Risi, E, Lai, A, Zanardi, E, Sini, V, Ziliani, S, Minuti, G, Mura, S, Grasso, D, Ferrarini, I, Pronzato, P, Del Mastro, L
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Corrigendum to ‘The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer’: [ESMO Open Volume 6, Issue 2, April 2021, 100078]
Banna, G.L., Cortellini, A., Cortinovis, D.L., Tiseo, M., Aerts, J.G.J.V., Barbieri, F., Giusti, R., Bria, E., Grossi, F., Pizzutilo, P., Berardi, R., Morabito, A., Genova, C., Mazzoni, F., Di Noia, V., Signorelli, D., Gelibter, A., Macerelli, M., Rastelli, F., Chiari, R., Rocco, D., Gori, S., De Tursi, M., Di Marino, P., Mansueto, G., Zoratto, F., Filetti, M., Montrone, M., Citarella, F., Marco, R., Cantini, L., Nigro, O., D'Argento, E., Buti, S., Minuti, G., Landi, L., Guaitoli, G., Lo Russo, G., De Toma, A., Donisi, C., Friedlaender, A., De Giglio, A., Metro, G., Porzio, G., Ficorella, C., Addeo, A.
Published in ESMO open (01.06.2021)
Published in ESMO open (01.06.2021)
Get full text
Journal Article
Consequences of targeted treatments for second-line therapy
De Maio, E., Tibaldi, C., D'Incecco, A., Bursi, S., Barbara, C., Cupini, S., Di Marsico, R., D'Arcangelo, M., Landi, L., Minuti, G., Cappuzzo, F.
Published in Annals of oncology (01.10.2010)
Published in Annals of oncology (01.10.2010)
Get full text
Journal Article
362P Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in head and neck squamous cell cancer (HNSCC)
Bossi, P., Minuti, G., Braña, I., Moreno Garcia, V., Boni, V., Jamme, P., Call, J.A., Yan, C., Barasa, B., Doze, P., Joe, A.K., Laus, G., Daste, A.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
EP.06F.03 Analysis of Copy Number Variations of MET, EGFR and ERBB2 Genes in a Lung Cancer Patient Series: Comparison of FISH with NGS
Buglioni, S., Ercolani, C., Di Benedetto, A., Terrenato, I., Palange, A., Americi, G., Visca, P., Pescarmona, E., Minuti, G., Landi, L., Cappuzzo, F.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
EP.09B.04 Neoadjuvant Chemo-Immunotherapy Followed by Radical Surgery for Synchronous Oligometastatic Non-Small Cell Lung Cancer
Gallina, F.T., Fusco, F., Cecere, F.L., Tajè, R., Forcella, D., Landi, L., Minuti, G., Buglioni, S., Visca, P., Melis, E., Facciolo, F., Cappuzzo, F.
Published in Journal of thoracic oncology (01.10.2024)
Published in Journal of thoracic oncology (01.10.2024)
Get full text
Journal Article
7036 Phase II study with pharmacodynamic evaluation of docetaxelprednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) as first line treatment in castration resistant prostate cancer (CRPC)
Fontana, A, Galli, L, Derosa, L, Minuti, G, D'Arcangelo, M, Bursi, S, Landi, L, Bocci, G, Santini, D, Falcone, A
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
1283P Advanced ALK-positive non-small cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database
Reale, M.L., Scattolin, D., Bria, E., Vitale, A., Grisanti, S., Costa, J., Galetta, D., Sini, C., Minuti, G., Citarella, F., Roca, E., Agustoni, F., Tiseo, M., Cortinovis, D.L., Pilotto, S., Ricciardi, S., Passiglia, F., Malapelle, U., Novello, S., Pasello, G.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1828P A cross-sectional study investigating the current diagnostic & therapeutical approaches to bone metastases (BoM) in patients (pts) with non-small cell lung cancer (NSCLC)
Pilotto, S., Avancini, A., Giaj-Levra, N., Minuti, G., Pasqualini, G., Colonese, F., Di Federico, A., Fozza, A., Montrone, M., Olmetto, E., Pastorello, E., Reale, M.L., Riva, S.T., Roca, E., Sini, C., Viscardi, G., Passiglia, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1403P Sotorasib in KRAS p.G12C mutated advanced NSCLC: Real-word data from the Italian Expanded Access Program
Reale, M.L., Passiglia, F., Brambilla, M., Pasello, G., Minuti, G., Bulotta, A., Pizzutilo, P., Sini, C., Costa, J., Roca, E., Bria, E., Pilotto, S., Genova, C., Metro, G., Citarella, F., Bordi, P., Russo, A., Chiari, R., Andrikou, K., Novello, S.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article